What is the appropriate treatment for persistent hiccups in the emergency department?

Treatment of Persistent Hiccups in the Emergency Department

Start with chlorpromazine 25-50 mg IV/IM, as it remains the only FDA-approved medication for hiccups, or alternatively use metoclopramide 10-20 mg IV, which has the strongest evidence base from randomized controlled trials.

Initial Approach: Non-Pharmacologic Maneuvers

Before pharmacotherapy, attempt vagal stimulation techniques 1:

• Nasopharyngeal stimulation using a nasal swab (PCR swab technique) - this novel approach showed immediate cessation of 72-hour persistent hiccups with sustained relief at 48 hours
• Traditional vagal maneuvers (breath-holding, Valsalva, drinking cold water)
• These are low-risk, immediately available interventions that may obviate medication need

First-Line Pharmacologic Treatment

When vagal maneuvers fail, the evidence supports several options, though none have robust comparative data 2:

Primary Agents (Choose One):

Metoclopramide 10-20 mg IV every 4-6 hours 3, 2

• Has randomized controlled trial evidence
• Dual mechanism: prokinetic + central antiemetic effects
• Readily available in ED settings
• Caution: Risk of extrapyramidal symptoms, especially in young patients and with prolonged use

Chlorpromazine 25-50 mg IV/IM

• Only FDA-approved agent specifically for hiccups
• Strong dopamine antagonist
• Caution: Significant sedation, hypotension risk; requires blood pressure monitoring

Haloperidol 0.5-2 mg IV/PO every 4-6 hours 3, 2

• Less sedating than chlorpromazine
• Effective dopamine blockade
• Better hemodynamic profile for ED use

Second-Line Options

If first-line agents fail or are contraindicated:

Baclofen 2

• Has randomized controlled trial evidence
• GABA-B agonist acting on hiccup reflex arc
• Requires oral dosing (not ideal for acute ED setting)

Gabapentin 2

• Studied prospectively
• Modulates central pathways
• Slower onset limits ED utility

Alternative/Adjunctive Approaches

Proton pump inhibitors (Pantoprazole 40 mg IV) 4

• Consider when gastroesophageal reflux suspected as trigger
• Recent case series showed benefit when combined with antihistamines
• Low risk profile

Benzodiazepines (Lorazepam 0.5-2 mg IV/PO) 3

• Useful as adjunct for anxiety component
• May potentiate other agents

Critical Pitfalls to Avoid

1. Don't dismiss persistent hiccups (>48 hours) - they signal potential serious underlying pathology requiring workup for CNS lesions, myocardial ischemia, or malignancy 5

2. Avoid promethazine IV through peripheral lines - central line only due to tissue necrosis risk 3

3. Monitor for extrapyramidal symptoms with dopamine antagonists, especially in younger patients

4. Don't use phrenic nerve blocks in the ED - recent case series 6 showed limited/temporary benefit with potential for symptom exacerbation; this is not an emergency intervention

Practical ED Algorithm

1. Attempt nasopharyngeal swab stimulation (5 seconds) 1 - immediate, safe, potentially curative
2. If unsuccessful, give metoclopramide 10-20 mg IV - best evidence, readily available
3. If contraindicated or ineffective, use haloperidol 1-2 mg IV - safer hemodynamic profile than chlorpromazine
4. Consider adding pantoprazole 40 mg IV if GI symptoms present 4
5. Reassess in 30-60 minutes; if persistent, consider admission for intractable hiccups workup

The systematic review 2 emphasizes that no specific agent has superior evidence, making the choice dependent on availability, contraindications, and side effect profile rather than efficacy data. The metoclopramide-first approach balances evidence quality with practical ED considerations.